AXIN2 and colitis: Inhibiting of Pygo2 attenuated the development of MAT lesions in Il‐10−/−mice by promoting the differentiation of adipocytes, reducing inflammation, and leading to the amelioration of colitis partly through the Axin2/GSK3β pathway.